<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38077784</PMID><DateRevised><Year>2023</Year><Month>12</Month><Day>11</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2451-9936</ISSN><JournalIssue CitedMedium="Internet"><Volume>32</Volume><PubDate><Year>2023</Year><Month>Dec</Month></PubDate></JournalIssue><Title>American journal of ophthalmology case reports</Title><ISOAbbreviation>Am J Ophthalmol Case Rep</ISOAbbreviation></Journal><ArticleTitle>Accelerated progression of diabetic retinopathy following severe COVID-19 infection.</ArticleTitle><Pagination><StartPage>101911</StartPage><MedlinePgn>101911</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">101911</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ajoc.2023.101911</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="UNASSIGNED">The impact of SARS-CoV-2 infection on pre-existing retinal pathology is currently unknown.</AbstractText><AbstractText Label="OBSERVATIONS" NlmCategory="UNASSIGNED">We present a unique case of rapidly progressing diabetic retinopathy (DR) following severe COVID-19 infection requiring supplemental oxygen and subsequent long-COVID.</AbstractText><AbstractText Label="CONCLUSIONS AND IMPORTANCE" NlmCategory="UNASSIGNED">Following infection with SARS-CoV-2, the associated acute and possible long-term hypoxia has the potential to affect the retina and accelerate the natural course of diabetic retinopathy.</AbstractText><CopyrightInformation>&#xa9; 2023 The Authors.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lyons</LastName><ForeName>Clayton E</ForeName><Initials>CE</Initials><AffiliationInfo><Affiliation>Department of Ophthalmology, Feinberg School of Medicine, Northwestern University, 645 N Michigan Avenue, Ste 440, Chicago, IL, 60611, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Ivy</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Ophthalmology, Feinberg School of Medicine, Northwestern University, 645 N Michigan Avenue, Ste 440, Chicago, IL, 60611, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gill</LastName><ForeName>Manjot K</ForeName><Initials>MK</Initials><AffiliationInfo><Affiliation>Department of Ophthalmology, Feinberg School of Medicine, Northwestern University, 645 N Michigan Avenue, Ste 440, Chicago, IL, 60611, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>08</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am J Ophthalmol Case Rep</MedlineTA><NlmUniqueID>101679941</NlmUniqueID><ISSNLinking>2451-9936</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Diabetic retinopathy</Keyword><Keyword MajorTopicYN="N">Hypoxia</Keyword><Keyword MajorTopicYN="N">Long-COVID</Keyword><Keyword MajorTopicYN="N">Retina</Keyword></KeywordList><CoiStatement>The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>4</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>7</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>8</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>12</Month><Day>11</Day><Hour>12</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>12</Month><Day>11</Day><Hour>12</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>12</Month><Day>11</Day><Hour>6</Hour><Minute>34</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>8</Month><Day>19</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38077784</ArticleId><ArticleId IdType="pmc">PMC10708989</ArticleId><ArticleId IdType="doi">10.1016/j.ajoc.2023.101911</ArticleId><ArticleId IdType="pii">S2451-9936(23)00119-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kaur C., Foulds W.S., Ling E.A. Hypoxia-ischemia and retinal ganglion cell damage. Clin Ophthalmol. 2008;2(4):879&#x2013;889. doi: 10.2147/opth.s3361. Accessed 3/31/23.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/opth.s3361</ArticleId><ArticleId IdType="pmc">PMC2699791</ArticleId><ArticleId IdType="pubmed">19668442</ArticleId></ArticleIdList></Reference><Reference><Citation>Ullah I., Sohail A., Shah M.U.F.A., et al. Central Retinal Vein Occlusion in patients with COVID-19 infection: a systematic review. Ann Med Surg (Lond). 2021;71 doi: 10.1016/j.amsu.2021.102898.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amsu.2021.102898</ArticleId><ArticleId IdType="pmc">PMC8500694</ArticleId><ArticleId IdType="pubmed">34659743</ArticleId></ArticleIdList></Reference><Reference><Citation>David J.A., Fivgas G.D. Acute macular neuroretinopathy associated with COVID-19 infection. Am J Ophthalmol Case Rep. 2021;24 doi: 10.1016/j.ajoc.2021.101232. Accessed 3/31/23.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajoc.2021.101232</ArticleId><ArticleId IdType="pmc">PMC8577875</ArticleId><ArticleId IdType="pubmed">34778601</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts K.A., Colley L., Agbaedeng T.A., Ellison-Hughes G.M., Ross M.D. Vascular manifestations of COVID-19 - thromboembolism and microvascular dysfunction. Front Cardiovasc Med. 2020;7 doi: 10.3389/fcvm.2020.598400. Published 2020 Oct 26. Accessed 3/31/23.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2020.598400</ArticleId><ArticleId IdType="pmc">PMC7649150</ArticleId><ArticleId IdType="pubmed">33195487</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C., Yu C., Jing H., et al. Long COVID: the nature of thrombotic sequelae determines the necessity of early anticoagulation. Front Cell Infect Microbiol. 2022;12 doi: 10.3389/fcimb.2022.861703. Published 2022 Apr 5. Accessed 3/31/23.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2022.861703</ArticleId><ArticleId IdType="pmc">PMC9016198</ArticleId><ArticleId IdType="pubmed">35449732</ArticleId></ArticleIdList></Reference><Reference><Citation>Feroze K.B. Retinal manifestations of COVID-19 disease - a review of available information. Kerala J Ophthalmol. May&#x2013;Aug 2021;33(2):132&#x2013;138. doi: 10.4103/kjo.kjo_131_21. Accessed 3/31/23.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/kjo.kjo_131_21</ArticleId></ArticleIdList></Reference><Reference><Citation>Zapata M.&#xc1;., Banderas Garc&#xed;a S., S&#xe1;nchez-Moltalv&#xe1; A., et al. Retinal microvascular abnormalities in patients after COVID-19 depending on disease severity. Br J Ophthalmol. 2022;106(4):559&#x2013;563. doi: 10.1136/bjophthalmol-2020-317953.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bjophthalmol-2020-317953</ArticleId><ArticleId IdType="pubmed">33328184</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>